Next, we determined whether the highly conserved “universal” CD8+ and CD4+ T-cell epitopes were differentially recognized by T cells from asymptomatic (ASYMP) versus symptomatic (SYMP) COVID-19 patients. This evidence concerns the gene CD8A and COVID-19.